Sidley Represents Laza Medical in Its US$160 Million Series B Financing Round

Sidley represented Laza Medical, Inc., a Shifamed portfolio company pioneering AI-powered robotic imaging solutions for cardiac interventions, in its Series B structured financing of up to US$160 million led by GE HealthCare, with participation from existing investors Unorthodox Ventures, PA MedTech, and AMED. The financing is intended to support Laza Medical’s mission to transform the cardiac catheterization laboratory through intelligent imaging technology and unlock the possibilities for future robotic-enabled interventions.

More about the transaction is available here.

The Sidley team was led by Frank Rahmani (Emerging Companies and Venture Capital), Nick DeAngelis (M&A), and Stephen Fronk (Technology and Life Sciences Transactions). The team included Jake Funk, Samantha Carvalho, Laura DeMassa, and Becca Davis (M&A); Dr. Idan Netser and Nathan Enfield (Tax); Nicholas Frey (Employee Benefits and Executive Compensation); Rebecca Stuart (Labor, Employment and Immigration); Jim Lowe and Miriam Carroll Silvestri (Antitrust and Competition); Diane McEnroe, Emily Marden, and Jaclyn Fonteyne (Food, Drug and Medical Device); Donielle McCutcheon and Kim Schroer (Healthcare); Sheri Porath Rockwell (Privacy and Cybersecurity); Paul Kariyawasam (Technology and Life Sciences Transactions); James Mendenhall (Global Arbitration, Trade and Advocacy); and Sarah Jehl (Environmental, Health and Safety).